Seifar F, Fox EJ, Shantaraman A, Liu Y, Modeste ES, Duong DM, Yin L, Gearing M, Lah JJ, Reddy JS, Allen M, Quicksall Z, Heath LM, Scanlan J, Wang E, Wang M, Linden AV, Poehlman WL, Chen X, Baheti S, Ho CCG, Nguyen T, Yepez‐Sisalema G, Mitchell AO, Oatman SR, Wang X, Carrasquillo MM, Runnels A, Beach TG, Golde T, Barnes LL, Haroutunian V, Zhang B, Jager PLD, Bennett DA, Greenwood A, Ertekin‐Taner N, Levey AI, Wingo AP, Wingo TS, Seyfried NT; Accelerating Medicine Partnership for Alzheimer’s (AMP‐AD) Diversity Initiative Disease. Proteomic Analysis Resolves Distinct Molecular Signatures in Alzheimer’s Disease Brain Across Diverse Racial Groups. Alzheimers Dement. 2025 Jan 9;20(Suppl 2):e092542. doi: 10.1002/alz.092542. PMCID: PMC11715113.